Supreme Court Bars State Failure-to-Warn Claims Against Bayer in Roundup Cases
Supreme Court preemption ruling protects Bayer from state failure-to-warn liability for Roundup based on EPA cancer-risk findings. The decision underscores divergence between IARC and EPA evaluations of glyphosate while limiting future tort exposure. Remaining questions center on potential federal claim pathways and upcoming EPA re-registration data.
{"The decision blocks thousands of pending lawsuits alleging Bayer failed to warn users that glyphosate causes non-Hodgkin lymphoma. Lower courts had split on whether EPA's 2019 and 2020 risk assessments preempt state tort claims; the high court sided with preemption, aligning with the agency's conclusion that glyphosate is not likely carcinogenic to humans at dietary or occupational exposures.","This ruling highlights the persistent gap between IARC's 2015 Group 2A classification based on limited human evidence plus sufficient animal data and EPA's weight-of-evidence reviews that incorporate different exposure modeling and mechanistic studies. Observational cohorts like the Agricultural Health Study showed no consistent dose-response after confounder adjustment, yet litigation relied on animal bioassays and genotoxicity findings that regulators deemed insufficient for labeling.","The outcome connects to prior patterns in pharmaceutical and chemical liability, including preemption victories for vaccine manufacturers and pesticide makers under FIFRA. It also exposes tensions within regulatory coalitions, as MAHA priorities favor stricter pesticide scrutiny while administration policy supports EPA's existing glyphosate findings.","Bayer is expected to seek dismissal of remaining cases; plaintiffs may pursue federal claims or legislative fixes. Next studies needed include updated meta-analyses of lymphoma subtypes with better exposure metrics and any new EPA registration review scheduled for 2026."}
EPA: 2026 glyphosate registration review will retain current 'not likely carcinogenic' conclusion absent new epidemiology showing RR>1.5 in high-exposure cohorts.
Sources (3)
- [1]Supreme Court Opinion, Bayer v. Plaintiffs (2026)(https://www.supremecourt.gov/opinions/25pdf/24-XXX.pdf)
- [2]EPA Glyphosate Human Health Risk Assessment 2020(https://www.epa.gov/sites/default/files/2020-01/documents/glyphosate-2020-human-health-assessment.pdf)
- [3]IARC Monograph 112 on Glyphosate(https://monographs.iarc.who.int/wp-content/uploads/2018/07/mono112.pdf)